0.83
+0.0102(+1.24%)
Currency In USD
| Previous Close | 0.82 |
| Open | 0.98 |
| Day High | 1 |
| Day Low | 0.81 |
| 52-Week High | 1.39 |
| 52-Week Low | 0.4 |
| Volume | 2.51M |
| Average Volume | 197,075 |
| Market Cap | 41.35M |
| PE | -5.19 |
| EPS | -0.16 |
| Moving Average 50 Days | 0.74 |
| Moving Average 200 Days | 0.81 |
| Change | 0.01 |
If you invested $1000 in NeuroOne Medical Technologies Corporation (NMTC) since IPO date, it would be worth $70.51 as of August 18, 2025 at a share price of $0.85. Whereas If you bought $1000 worth of NeuroOne Medical Technologies Corporation (NMTC) shares 5 years ago, it would be worth $157.46 as of August 18, 2025 at a share price of $0.85.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
GlobeNewswire Inc.
8 hours ago
FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOn
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update
GlobeNewswire Inc.
Jul 31, 2025 4:12 PM GMT
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients sufferi
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time
GlobeNewswire Inc.
Jul 31, 2025 12:30 PM GMT
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients sufferi